Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 76-100 of 606 matching filings.

Per page
25
Current page
4
SCHEDULE 13D/A File 005-88628

SCHEDULE 13D/A filing

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88628

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2024
Reporting date
21 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2024
Reporting date
21 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2024
Reporting date
21 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2024
Reporting date
21 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2024
Reporting date
21 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88628

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Nov 2024
Reporting date
08 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Nov 2024
Reporting date
08 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
23 Sep 2024
Reporting date
12 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Sep 2024
Reporting date
09 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88628

SC 13D filing

Filing date
12 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .